chrisvoncsefalvay/vaers-outcomes huggingface dataset:
19 days after the vaccine,  I started to have some rash on the forehead, swollen left eye the next day.  I thought it was allergies, but it didn?t get better with antihistamines, triamcinolone,  and antibiotic .  I went to the urgent clinic on the third day and was diagnosed with Shingles. I am prescribed with acyclovir for treatment. I am not sure if it?s related to the vaccine but something triggered it and I?m not in the normal age group that gets it.
Patient did not return to get the 2nd dose of Moderna; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Patient did not return to get the 2nd dose of Moderna) and NO ADVERSE EVENT (No adverse event) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On 17-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Patient did not return to get the 2nd dose of Moderna) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Patient did not return to get the 2nd dose of Moderna) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (Patient did not return to get the 2nd dose of Moderna).    Concomitant product use was not provided by the reporter.  It was reported that the patient did not return to get the second dose of Moderna. Patient did not had adverse reactions.  Treatment information was not provided.
Onset of sxs 4 days post 2nd Pfizer COVID vaccine while standing in the kitchen looking for paperwork Noticed she felt shaky, heart pain with burning, pulse was "going crazy" and going up, hard to focus HR 173 (pulse 160 when the paramedics arrived) Called 9-1-1 Deep burning in her heart Felt like my body was going to explode Whole body painful  Vision blurry  Pain in teeth Hands were purple and cold - hx of Raynaud's but never had these sxs
Severe headache, body aches and leg pain that persisted for 36 hours, until I started taking heavy doses of Advil (800 mg every 4 hours).
Swelling of the injection site. Ice. Benadryl if receiving 50 mg.
fever, intense headache, and muscle aches- started about 8 hours after the shot- worst was overnight. Morning still have body aches and headache but the fever has gone down to 99 degrees F
I have not yet determined the cause but since Nov 2 (12 days after I got the booster shot) I've been having rashes/hives that flare up and then go away. The itching is greatly reduced by Zyrtec or Benadryl. The rashes are blotchy and irregular in shape, streaky red lines (especially after itching/rubbing) and sometimes reduce to smaller spots and appear on torso/back/wrists/armpits--frequently after minor contact such as on my wrist after putting my watch on.
1st pap: 7/21/2010 @ 17 y.o. results = low grade squamous intraepithelial lesion (C1NI/HPV effect).
It has been about 7 weeks since the first; Missed dose of the Vaccine; Rash on her face; Shingles; Rash on her eyebrow and near the eye; Ear bothering her; Persistent headaches; This is a spontaneous Initial report from a contactable consumer (patient) reported for herself. A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Lot/Batch number: EN6207, Expiration date: Unknown), via an unspecified route in left arm on 17Mar2021 (age at vaccination: 41-year-old), as a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included multivitamins started taking about 5 years ago for good health, prenatal and general women's health vitamin. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. On 01Apr2021 (three week after the vaccine), started getting persistent headaches, on 03Apr2021, early evening around 17:00 or 18:00, patient experienced pain started, thought she had an ear infection or something, ear bothering her, the pain started, thought she had an ear infection or something and on 06Apr2021 (2 weeks later) when she woke up in the morning on Tuesday, patient developed shingles/herpes zoster, rash on her face and around her eyes (on her eyebrow near her eye). Patient was wondering when she can get second injection. It has been about 7 weeks since the first (missed dose of the Vaccine). The eye doctor she went to said to wait 2-3 months to give body time to heal and make sure her immune system would be strong for the second Pfizer covid-19 injection. Patient is fine waiting for the next vaccine. Her eye doctor told her to wait but, she called Pfizer wondering if there are any guidelines. She wants her immune system to recover from this and this be out her system. She went to Urgent Care and was prescribed Valtrex (antiviral) as treatment and she finished taking Valtrex. For the shingles rash on her face for over a week, about 7 days. She had blisters that opened and then they scabbed. They are not visible but, she can still see what is left of them. It was a week or two ago they started to go away she believes. Adverse events did not result in emergency room visit. She needs to make a decision on whether she should get the next dose or not. The clinical outcome of the event ear bothering her was recovered on 10Apr2021, persistent headaches was recovered on 14Apr2021, shingles, rash on face, rash on her eyebrow was recovered on 21Apr2021 and missed second dose was unknown.  No follow-up attempts are needed. No further information is expected.
worst flu; Initial information was received on 16-Nov-2021 regarding an unsolicited valid non-serious case received from social media from consumer/non-health care professional via Medical information (under reference number - US-SA-SAC20211123000304)  This case involves a patient of (unknown demographics) who experienced worst flu (influenza), after receiving vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, concomitant medication(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious worst flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  No additional laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on batch number for this case.
chills; cough; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Historical vaccine included 1st dose of BNT162B2 (Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date for COVID-19 immunization and experienced shortness of breath, palpitations, scratchy throat. Medical history included patient had high blood pressure and took medicine for it. The patient's concomitant medications were not reported. After 2nd vaccine, symptoms were less severe but, the patient experienced chills, cough and headache on an unspecified date. Patient went to ER was checked and no problems were found with her heart or lungs. Labs were normal. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Patient did not wait 15 minutes after receiving the 1st dose.  As she was driving 5 minutes later, she became dizzy and pulled over and fell asleep for 2.5 hrs. When she woke, patient could not see, dizzy, heart racing and got back into her car and blacked out. The car rolled and hit another vehicle creating a loud bang which woke her. She was instructed to go to the ED but refused.
Widespread rash, red, raised, mild itching, some on soles of feet, at least three days in duration
a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day.; Covid-19 Vaccination, she experienced a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day.; This is a spontaneous report from a contactable consumer, the patient.  A 80-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration on 12Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On Feb2021,  The patient experienced a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day. The clinical course is as follows after her second Pfizer Covid-19 Vaccination, she experienced a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day. Caller stated she received her second Pfizer Covid-19 Vaccine 12Feb2021. Patient  is scheduled for bone density test. Caller stated, 'they said I should wait 2 weeks prior to. It will be 11 days.' Caller asked will her bone density test have any effect on her vaccination. The clinical outcome of the events was unknown.      Information on the lot/batch number has been requested.
Very hot injection site; Swollen injection site; Painful injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Very hot injection site), VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Painful injection site) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939905, 001BZ1A and 028A21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: pneumonia (Years ago). Past adverse reactions to the above products included Adverse reaction with pneumonia.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021 at 10:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021 at 12:00 PM, the patient experienced VACCINATION SITE WARMTH (Very hot injection site), VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Painful injection site). The patient was treated with TRAMADOL for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Very hot injection site), VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Painful injection site) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Body temperature: high (High) Body temperature is 98.1.         No concomitant medication details were provided. Pain is really bad Treatment included ice pack, symptoms turned down little bit.
Inflammation in the entire upper body.  We have been to ER twice.  Ruled out pulmonary embolism, had echo gram (no heart problem), had upper GI endoscopy (negative), went to Rheumatologist? and sent to physical therapy and at inflammatories.  Nothing is helping. Getting worse.  PT says he can?t do much because inflammation is so bad and entire body is so painful to touch.  Referred to pain management, but no openings until December.  Getting worse everyday.  Ices down all day.  Can?t sing in choir anymore, can?t swim in swim team, having trouble attending school.  Always exhausted.  We need help!!!!
It is eight days since I received the Covid shot.  I am fine, but today my wife noticed a red halo type image around the area where I received the shot on February 3rd.  It probably is nothing, but I thought that it would be good to  let you know.
Pt got a dose of Shingrix subcutaneously; This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.   Additional Information: GSK Receipt Date: 2-May-2022 Reporter's comments: The patient received Shingrix subcutaneously. No symptoms reported. The consent to follow up was given by mail. The healthcare professional did not have the patient's date of birth or any vaccination details at time of report. Additional Supportive Information: The patient received Shingrix subcutaneously, which led to intramuscular formulation administered by other route.
fatigue; Headache that began at back of head and progressed to the front of the head; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jan2021 (Lot number: EL9262) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 30Jan2021, outcome "recovered", described as "fatigue"; HEADACHE (non-serious) with onset 30Jan2021, outcome "recovered", described as "Headache that began at back of head and progressed to the front of the head". Therapeutic measures were taken as a result of fatigue, headache. Additional information: It was reported that the patient received dose 2 on an unspecified date on Feb2021. It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was also unknown if patient was allergic to medications, food, and other products. The patient received Tylenol and Imitrex as treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if patient been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
3 Days he was immobilized, could not move his legs at all.  He had a huge lump on his arm.
cerebrovascular accident (left hemispheral language area) - DWI-negative stroke vs TIA
I could not talk at all. It was excruciating pain in all of my throat. I needed a pain killer. I was breathing heavily like a purring cat or Darth Vader. I have runny nose, coughing, and spitting.
The patient is not having adverse signs and symptoms at this time; have a patient in my office, and I gave him a PNEUMOVAX 23 vaccine that expired on 03-DEC-2020; This spontaneous report was received from a physician referring to a 66-year-old male patient. The patient's concurrent conditions included thyroid disorder, hypertension, dyslipidaemia, and lipids increased. His medical history and drug reactions/allergies were not reported. Concomitant medications included levothyroxine sodium, atorvastatin, and amlodipine.  On 04-DEC-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliter, intramuscular injection in the left arm (lot number not provided), with an expiration date reported as 03-DEC-2020 (expired product administered) for routine immunization for patients 65 and older. The reporter wanted to know if it was okay to give the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) past the expiration date. No treatment was given, the patient did not seek medical attention, and the present status was reported as recovered. At the time of the report, the patient was not having adverse signs and symptoms. No product quality complaint reported.
tested positive for covid; tested positive for covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2 (BNT162B2), on 06Feb2021 as dose 1, single (Lot number: EM9810), on 20Mar2021 as dose 2, single (Lot number: ER8727), on 10Sep2021 as dose 3 (booster), single (Lot number: FC3184) and on 05Apr2022 (forgot if it was in the morning or afternoon) as dose 4 (booster), single (Lot number: FK9893) at the age of 69 years, in right arm (cannot get in left arm due to breast cancer) for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer", start date: Oct2020 (unspecified if ongoing), notes: Breast cancer. No family medical history relevant to event. Concomitant medication(s) included: LETROZOLE oral taken for breast cancer, start date: Feb2021. Vaccination history included: Flu vaccine (Took flu vaccine in fall and she is fine and takes them all the time), for immunization. No prior vaccinations (within 4 weeks). The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Weight: 179-180 lbs. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient did not have any reactions to these covid vaccines. Her husband traveled and brought home with covid him. She always uses a mask. Patient diagnosed with covid after four doses of Pfizer covid vaccine, tested positive for covid and was prescribed Paxlovid. No Emergency Room or Physician Office required. No relevant tests.  Follow-up attempts are completed. No further information is expected.
This case was reported by a other health professional via sales rep and described the occurrence of anaphylaxis in a 37-year-old female patient who received FLUARIX QUADRIVALENT (batch number 29PD2, expiry date June 2017). Previously administered products included Flu vaccine with an associated reaction of adverse reaction (for tolerance to previous dose of Flu vaccine, refer case US2016GSK167847). On an unknown date, the patient received FLUARIX QUADRIVALENT. On an unknown date, 10 min after receiving FLUARIX QUADRIVALENT, the patient experienced anaphylaxis (serious criteria GSK medically significant), allergic reaction, hives, pruritus and shortness of breath. The patient was treated with BENADRYL. On an unknown date, the outcome of the anaphylaxis, allergic reaction, hives, pruritus and shortness of breath were recovered/resolved. The reporter considered the anaphylaxis, allergic reaction, hives, pruritus and shortness of breath to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The patient's age at vaccination was not reported. The events were resolved after administration of BENADRYL. The patient did not require hospital visit. The reporter did not know if it was actually anaphylaxis or just an allergic reaction. This was 2nd of 5 cases reported by the same reporter. This case was linked to US2016GSK167847, as reported by the same patient.
Info has been received from a physician concerning a 4 year old male with asthma who on 1/25/05 was vaccinated, SC, with a 0.5ml dose of varicella virus vaccine live (lot 641151/1181L). Concomitant therapy included fluticasone propionate (Flovent). On 11/14/05, the pt experienced a breakthrough case of 10 lesions and no fever. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional info has been requested.
patient had moderna covid vaccine on 4-26-21, administered in his left arm.  He states that within a week he started having pain in his left foot that eventually moved up to just below his knee.  This included swelling.  He saw his physician, who began treating him for gout.  His also said that he felt off and insisted that his doctor checks his blood sugar, although he had no previous issues with his blood sugars.  He came back at a 241.  He is now taking allopurinol and metformin.  The pain and swelling in his left leg is subsiding now.  He did go thru one period of 4 days where he said he could not stand on his left leg.  He was due for his second shot today, 5/24/21, but chose not to out of caution, until his doctor figures out what is going on.  Also, his dietician recommended he not get the vaccine at this time
Patient received flu vaccine with no issue, upon receiving Covid vaccine around 3:52PM, patient fainted for roughly 30 to 45 seconds. After regaining consciousness, patient attempted to stand up, and was told to remain seated by the pharmacist while the EMTs arrived.
Headache; Nauseated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Lot number: 517121) at the age of 57 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; CHLORTHALIDONE. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization.  The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache"; NAUSEA (non-serious), outcome "unknown", described as "Nauseated".  Additional information: The patient stated that after the patient took the Covid vaccine shot on Friday and now she had been getting headache and had been feeling nauseated little bit. The first one was fine but the second one was not.  No follow-up attempts are possible. No further information is expected.
This was a 12 year 1 month child and was inadvertently given the Pfizer COVID vaccine for 5-11 year for her first dose of the vaccine. She should have got the Pfizer COVID 12+.  I called Pfizer and explained what happened and they said recommendations was to not re vaccinate but to give the 12+ dose for the second dose to complete the series.